HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Norman Wolmark Selected Research

Raloxifene (Evista)

1/2015A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
7/2013Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.
4/2013National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.
11/2012Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).
4/2012Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.
12/2011Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
11/2011Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.
6/2010Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
1/2010Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.
1/2009The use of tamoxifen and raloxifene for the prevention of breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Norman Wolmark Research Topics

Disease

83Breast Neoplasms (Breast Cancer)
09/2015 - 06/2002
48Neoplasms (Cancer)
11/2015 - 06/2002
21Colonic Neoplasms (Colon Cancer)
12/2013 - 01/2003
7Carcinoma (Carcinomatosis)
01/2011 - 10/2002
6Neutropenia
09/2015 - 12/2007
6Noninfiltrating Intraductal Carcinoma (DCIS)
11/2013 - 08/2007
4Colorectal Neoplasms (Colorectal Cancer)
11/2012 - 08/2003
3Diarrhea
11/2015 - 11/2007
3Hemorrhage
09/2012 - 07/2009
3Neoplasm Metastasis (Metastasis)
07/2012 - 08/2002
3Uterine Neoplasms (Uterine Cancer)
12/2011 - 06/2006
3Amenorrhea
03/2011 - 01/2009
3Hyperplasia
06/2010 - 02/2003
2Rectal Neoplasms (Rectal Cancer)
11/2015 - 06/2014
2Fatigue
09/2015 - 08/2011
2Hypertension (High Blood Pressure)
09/2015 - 01/2012
2Heart Failure
11/2013 - 10/2005
2Microsatellite Instability
12/2012 - 03/2007
2Hypesthesia (Numbness)
11/2012 - 06/2007
2Mucositis
01/2012 - 08/2011
2Polyps
12/2011 - 04/2005
2Ovarian Cysts (Ovarian Cyst)
12/2011 - 04/2005
2Leiomyoma (Uterine Fibroids)
12/2011 - 04/2005
2Endometrial Hyperplasia
12/2011 - 04/2005
2Endometrial Neoplasms (Endometrial Cancer)
06/2010 - 11/2005
2Venous Thrombosis (Deep-Vein Thrombosis)
07/2006 - 11/2005
2Osteoporosis
06/2006 - 06/2002
2Cataract (Cataracts)
06/2006 - 11/2005
2Adenocarcinoma
09/2005 - 08/2004
1Sudden Death
09/2015
1Endocarditis
09/2015
1Osteonecrosis (Kienbock's Disease)
07/2012
1Liver Diseases (Liver Disease)
07/2012
1Body Weight (Weight, Body)
01/2012
1Hot Flashes
12/2011
1Vaginal Discharge
12/2011
1Headache (Headaches)
08/2011
1Inflammatory Breast Neoplasms
08/2011
1Carcinoma in Situ
01/2010
1Cicatrix (Scar)
11/2008

Drug/Important Bio-Agent (IBA)

41TamoxifenFDA LinkGeneric
09/2015 - 06/2002
23Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 06/2002
22Fluorouracil (Carac)FDA LinkGeneric
11/2015 - 01/2003
22Doxorubicin (Adriamycin)FDA LinkGeneric
09/2015 - 06/2002
21Estrogens (Estrogen)FDA Link
11/2012 - 04/2004
16trastuzumab (Herceptin)FDA Link
04/2015 - 06/2002
15oxaliplatin (Eloxatin)FDA LinkGeneric
11/2015 - 09/2005
14Raloxifene (Evista)FDA Link
01/2015 - 06/2002
14Leucovorin (Folinic Acid)FDA Link
12/2013 - 01/2003
13Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 06/2002
11docetaxel (Taxotere)FDA Link
09/2015 - 10/2002
8bevacizumabFDA Link
09/2015 - 07/2009
8B 31IBA
04/2015 - 06/2002
7Epidermal Growth Factor Receptor (EGF Receptor)IBA
04/2015 - 11/2005
6HormonesIBA
07/2014 - 01/2006
6ParaffinIBA
12/2013 - 12/2004
5capecitabine (Xeloda)FDA Link
11/2015 - 08/2011
5P-2 (P 2)IBA
01/2015 - 06/2006
5desintegron BIBA
11/2011 - 12/2004
4gemcitabineFDA Link
09/2015 - 06/2008
4Selective Estrogen Receptor Modulators (SERM)IBA
01/2015 - 06/2010
4AnthracyclinesIBA
11/2012 - 11/2005
3Progesterone Receptors (Progesterone Receptor)IBA
04/2012 - 01/2005
2taxaneIBA
12/2013 - 09/2013
2Dihydrotachysterol (AT 10)IBA
04/2012 - 08/2006
2TaxoidsIBA
01/2012 - 06/2010
2Sodium Glutamate (Accent)IBA
10/2011 - 01/2010
2RNA (Ribonucleic Acid)IBA
09/2010 - 06/2008
2Epirubicin (Ellence)FDA LinkGeneric
02/2010 - 06/2008
2UracilIBA
02/2007 - 05/2006
2TegafurIBA
02/2007 - 05/2006
2letrozole (Femara)FDA LinkGeneric
12/2006 - 11/2003
2Methotrexate (Mexate)FDA LinkGeneric
12/2004 - 07/2004
1Octreotide (Sandostatin)FDA LinkGeneric
09/2015
12- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
07/2015
1Biological Markers (Surrogate Marker)IBA
04/2015
1N- (4- (3- chloro- 4- (2- pyridinylmethoxy)anilino)- 3- cyano- 7- ethoxy- 6- quinolyl)- 4- (dimethylamino)- 2- butenamideIBA
12/2013
1lapatinib (GW572016)FDA Link
11/2013
1B 43IBA
11/2013
1DNA (Deoxyribonucleic Acid)IBA
07/2013
1Clodronic Acid (Clodronate)IBA
07/2012
1AntimetabolitesIBA
01/2012
1anastrozole (Arimidex)FDA LinkGeneric
11/2011
1Messenger RNA (mRNA)IBA
11/2011
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2011
1albumin-bound paclitaxelFDA Link
02/2010
1tau Proteins (tau Protein)IBA
09/2009
1Monoclonal AntibodiesIBA
10/2008

Therapy/Procedure

29Drug Therapy (Chemotherapy)
11/2015 - 08/2002
21Adjuvant Chemotherapy
11/2014 - 08/2004
13Segmental Mastectomy (Lumpectomy)
07/2015 - 10/2002
6Mastectomy (Mammectomy)
02/2014 - 11/2004
6Radiotherapy
03/2011 - 10/2003
5Chemoprevention
04/2013 - 01/2006
4Neoadjuvant Therapy
07/2014 - 10/2002
3Lymph Node Excision (Lymph Node Dissection)
10/2010 - 08/2007
2Combination Drug Therapy (Combination Chemotherapy)
11/2014 - 09/2013
2Radical Mastectomy
10/2008 - 08/2002
2Simple Mastectomy
10/2008 - 10/2002
1Adjuvant Radiotherapy
11/2012